Studien | Der Arzneimittelbrief

ACRIN/GOG

American College of Radiology Imaging Network

ACRIS-MICABG

Complete Revascularization Via Inferior Part-sternotomy

ACRNaCT

Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

ACRO-POLIS

Description of Sign-and-symptom Associations at Acromegaly Diagnosis

ACROBAT Advance

A Study to Evaluate the Long-Term Safety and Efficacy of Paltusotine for the Treatment of Acromegaly

ACROBAT Edge

An Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly

ACROBAT Evolve

Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine

ACROINNOVA 1

Octreotide Subcutaneous Depot for Acromegaly

ACROSS

Australasian Cooperative Research On Subarachnoid hemorrhage Study

ACROSS T2D

Academy for Cardiovascular Risk, Outcomes and Safety Studies in Type 2 Diabetes

ACROSS/TOSCA-4

Approaches to Chronic Occlusions With Sirolimus-Eluting Stents/Total Occlusion Study of Coronary Arteries-4

ACROSS1

Almonertinib Plus Chemotherapy as First-line Treatment in Patients With EGFR Concomitant Non-EGFR Driver Gene Mutant, Locally Advanced or Metastatic NSCLC

ACS CPS-II

American Cancer Society's second Cancer Prevention Study-II

ACS I

Canadian Acute Coronary Syndrome registries I

ACS II

Canadian Acute Coronary Syndrome registries II

ACSRS

Asymptomatic Carotid Stenosis and Risk of Stroke

ACSUS

AIDS Cost and Services Utilisation Study

ACT

Acetylcysteine for Contrast-induced nephropathy Trial

AcT

Alteplase Compared to Tenecteplase in Patients With Acute Ischemic Stroke

ACT

Effects of Combined Aerobic Exercise and Cognitive Training in MCI

ACT 10

Amoxycillin-Clarithromycin Triple therapy 10

ACT 2

Acceptability and Feasibility of Combination Treatment for Cervical Precancer Among South African Women Living With HIV

ACT DMD

Phase 3 Study of Ataluren in Participants With Nonsense Mutation Duchenne Muscular Dystrophy (nmDMD)

ACT HIV

Adjunctive Corticosteroids for Tuberculous meningitis in HIV-infected adults

ACT NOW

ACtos Now for Prevention of Diabetes study

Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant

ACT-AD

Advantage of cerebellar intermittent theta-burst stimulation in Alzheimer's disease

ACT-DL

Efficacy of Acceptance and Commitment Therapy in Daily Life in early psychosis

ACT-FAST

Ambulance Clinical Triage for Acute Stroke Treatment

ACT-GLOBAL

Adaptive Platform Trial for Stroke

ACT-HIV

Adjunctive Corticosteroids for Tuberculous Meningitis in HIV-infected Adults

ACT-IC

Acceptance and commitment therapy (ACT) for informal caregivers

ACT-ICU

Activity and Cognitive Therapy in ICU

ACT-ONE

A Clinical Study With MT-102 in Subjects With Cancer Cachexia

ACT-RAY

Adding Tocilizumab or Switching to Tocilizumab Monotherapy in Methotrexate Inadequate Responders

ACT-RAY MRI

Adding Tocilizumab or Switching to Tocilizumab Monotherapy in Methotrexate Inadequate Responders MRI

ACT-SURE

Median time to low disease activity is shorter in tocilizumab combination therapy with csDMARDs as compared to tocilizumab monotherapy in patients with active rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors

ACT-TBM

Aspirin or Clopidogrel Therapy in the Treatment of Tuberculous Meningitis

ACT1ON

Advancing Care for Type 1 Diabetes and Obesity Network energy metabolism and sequential multiple assignment randomized trial nutrition

ACT1VATE

Addressing emotional distress to improve outcomes in adults with type 1 diabetes

ACT2

Active Case finding in Tuberculosis

ACTA

A phase III, randomised, controlled trial for the treatment of HIV-associated cryptococcal meningitis: oral fluconazole plus flucytosine or one week amphotericin B-based therapy vs two weeks amphotericin B-based therapy